http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2166220-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6a6487902840957ea22664781405d8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| filingDate | 1971-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_529a2b3cd52bb1c81a53782bc1c0d000 |
| publicationDate | 1973-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2166220-A1 |
| titleOfInvention | VIROSTATICALLY EFFECTIVE MEDICINE |
| abstract | Virustatic compositions contg. more than 0.5% thymidine (I). Unlike known virustatic agents such as 5-iodo- or 5-ethyl-desoxyuridine, (I) has no teratogenic or mutagenic activity; and is more readily available (from natural sources). Pref. composition contains 2-5% (I) as parenteral solutions in sterile water. EXAMPLE 50 hamsters were infected with a herpes virus suspension (applied topically), then divided into 5 groups of 10. Four groups received various amts. of (I); the fifth was a control. Results were: Animals received (I) for 10 days before infection. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8300436-A1 |
| priorityDate | 1971-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.